ProfileGDS4132 / 203209_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 27% 34% 27% 29% 33% 32% 30% 37% 26% 28% 21% 27% 24% 33% 26% 26% 30% 24% 26% 26% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10166.516427
GSM201543Muscle PCOS pioglitazone 12177.917434
GSM201544Muscle PCOS pioglitazone 16167.059627
GSM201545Muscle PCOS pioglitazone 20179.63529
GSM201829Muscle PCOS pioglitazone 23188.656533
GSM201830Muscle PCOS pioglitazon 25183.49632
GSM201831Muscle PCOS pioglitazone 27169.935330
GSM201832Muscle PCOS pioglitazone 3195.719337
GSM201833Muscle PCOS pioglitazone 4157.724726
GSM201834Muscle PCOS pioglitazone 8164.325928
GSM201835Muscle PCOS after pioglitazone 10236.993621
GSM201836Muscle PCOS after pioglitazone 12255.21627
GSM201837Muscle PCOS after pioglitazone 16244.483124
GSM201838Muscle PCOS after pioglitazone 20274.210633
GSM201839Muscle PCOS after pioglitazone 23256.035826
GSM201840Muscle PCOS after pioglitazone 25257.686226
GSM201841Muscle PCOS after pioglitazone 27259.464130
GSM201842Muscle PCOS after pioglitazone 3242.396824
GSM201843Muscle PCOS after pioglitazone 4261.290426
GSM201844Muscle PCOS after pioglitazone 8257.671326